(Q71619740)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8843588%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

title

Thalidomide prolonged graft survival in a rat cardiac transplant model but had no inhibitory effect on lymphocyte function in vitro (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8843588%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8843588%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Zhongquan Qi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8843588%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

author name string

Ostraat O

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8843588%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Eriksson T

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8843588%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Schatz H

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8843588%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Ekberg H

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8843588%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

publication date

1 June 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8843588%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

published in

Transplant Immunology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8843588%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8843588%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

117-125

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8843588%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8843588%20AND%20SRC:MED&resulttype=core&format=json

THALIDOMIDE IN THE TREATMENT OF LEPRA REACTIONS

20 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2896%2980005-0

7 January 2021

Treatment of ulcerative colitis with thalidomide

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2896%2980005-0

7 January 2021

Thalidomide in painful AIDS-associated proctitis

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2896%2980005-0

7 January 2021

Thalidomide: treatment of choice for aphthous ulcers in patients seropositive for human immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2896%2980005-0

7 January 2021

PROLONGATION OF SKIN HOMOGRAFT SURVIVAL BY THALIDOMIDE.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2896%2980005-0

7 January 2021

Treatment and prevention of acute graft-versus-host disease with thalidomide in a rat model

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2896%2980005-0

7 January 2021

Combination thalidomide and cyclosporine for cardiac allograft rejection. Comparison with combination methylprednisolone and cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2896%2980005-0

7 January 2021

Beneficial effect of thalidomide and ciclosporin combination in heterotopic cardiac transplantation in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2896%2980005-0

7 January 2021

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2896%2980005-0

7 January 2021

Thalidomide inhibits the replication of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2896%2980005-0

7 January 2021

Thalidomide derivatives and the immune system. I. Changes in the pattern of integrin receptors and other surface markers on T lymphocyte subpopulations of marmoset blood.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2896%2980005-0

7 January 2021

Thalidomide and the immune system 2. Changes in receptors on blood cells of a healthy volunteer

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2896%2980005-0

7 January 2021

Effect of thalidomide on the antibody response

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2896%2980005-0

7 January 2021

Effects of thalidomide and its derivatives on human leucocytes cultured in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2896%2980005-0

7 January 2021

Thalidomide teratogenesis: evidence for a toxic arene oxide metabolite

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2896%2980005-0

7 January 2021

Teratogen metabolism: activation of thalidomide and thalidomide analogues to products that inhibit the attachment of cells to concanavalin A coated plastic surfaces

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2896%2980005-0

7 January 2021

Induction of morphological differentiation in the human leukemic cell line K562 by exposure to thalidomide metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2896%2980005-0

7 January 2021

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2896%2980005-0

7 January 2021

Revised methods for the Salmonella mutagenicity test

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2896%2980005-0

7 January 2021

Determination of thalidomide in plasma and blood by high-performance liquid chromatography: avoiding hydrolytic degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2896%2980005-0

7 January 2021

Immunosuppressive activity of FK-506 in rats: flow cytometric analysis of lymphocyte populations in blood, spleen and thymus during treatment and following drug withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2896%2980005-0

7 January 2021

T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2896%2980005-0

7 January 2021

Indirect presentation of MHC antigens in transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2896%2980005-0

7 January 2021

The Influence of Thalidomide on the Clinical and Immunologic Manifestation of Erythema Nodosum Leprosum

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2896%2980005-0

7 January 2021

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2896%2980005-0

7 January 2021

Tumor necrosis factor production during human renal allograft rejection is associated with depression of plasma protein C and free protein S levels and decreased intragraft thrombomodulin expression

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2896%2980005-0

7 January 2021

The pathophysiology of tumor necrosis factors

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2896%2980005-0

7 January 2021

10.1016/S0966-3274(96)80005-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8843588%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference